Vous avez cherché: multifocal (Anglais - Maltais)

multifocal motor neuropathy
newropatija motriċi multifokali

progressive multifocal leukoencephalopathy (pml)
lewkoenċefalopatija multifokali progressiva (pml)

multifocal multisystem langerhans cell histiocytosis
sindrome ta' abt-letterer-siwe

leukoencephalopathy including progressive multifocal leukoencephalopathy
lewkoenċefalopatija li tinkludi lewkoenċefalopatija multifokali progressiva

progressive multifocal leukoencephalopathy (also called “pml”)
lewkoenċefalopatija multifokali progressiva (imsejħa wkoll “pml” [progressive multifocal leukoencephalopathy])

if your doctor has told you that you have pml (progressive multifocal leukoencephalopathy).
jekk it-tabib tiegħek qallek li għandek pml (lewkoenċefalopatija multifokali progressiva).

progressive multifocal leukoencephalopathy (pml) has been reported with benlysta treatment for sle.
lewkoenċefalopatija multifokali progressiva (pml - progressive multifocal leukoencephalopathy) ġiet irrappurtata b’kura b’benlysta għal sle.

progressive multifocal leukoencephalopathy (pml) is a serious and life threatening brain infection.
lewkoenċefalopatija multifokali progressiva (pml -progressive multifocal leukoencephalopathy) hija infezzjoni fil-moħħ serja u ta’ periklu għall-ħajja.

there was a single additional report of biopsy confirmed progressive multifocal leukoencephalopathy in the adult population.
kien hemm rapport addizzjonali wieħed ta 'bijopsija li kkonfermat lewkoenċefalopatija progressiva f' aktar minn post wieħed fil- popolazzjoni adulta.

the use of raptiva may be associated with an increased risk of progressive multifocal leukoencephalopathy (pml).
l- użu ta 'raptiva jista ’ jiġi assoċjat ma' riskju ta 'lewkoenkefalopatija progressiva multifokali (pml).

cases of progressive multifocal leukoencephalopathy with fatal outcome have been reported following use of mabthera for the treatment of autoimmune diseases.
wara l-użu ta’ mabthera għall-kura ta’ mard awtoimmuni kienu rrappurtati każijiet ta’ lewkoenċefalopatija multifokali progressiva (pml) b’riżultat fatali.

aseptic meningitis*, severe infections*, jc virus infection resulting in progressive multifocal leukoencephalopathy*
meninġite assetika *, infezzjonijiet severi *, infezzjoni tal - jc virus riżultanti f' lewkoenkefa lopatija progressiva multifokali *

due to the potential for progressive multifocal leukoencephalopathy (pml), patients should be monitored for signs and symptoms.
minħabba l-potenzjal ta’ lewkoenċefalopatija multifokali progressiva (pml - progressive multifocal leukoencephalopathy) il-pazjenti għandhom ikunu mmonitorjati għal sinjali u sintomi.

fungal infection of brain, inflammation of the brain, serious brain infection called pml (progressive multifocal leukoencephalopathy)
infezzjoni fungali tal-moħħ, infjammazzjoni tal-moħħ, infezzjoni serja fil-moħħ imsejħa pml (lewkoenċefalopatija multifokali progressiva)

progressive multifocal leukoencephalopathy (pml), a serious and life threatening brain condition, has been reported with medicines like arzerra.
lewkoenċefalopatija multifokali progressiva (pml), kundizzjoni tal-moħħ serja u ta’ periklu għall- ħajja, kienet irrappurtata b’mediċini bħal arzerra.

in dogs, simeprevir was associated with a reversible multifocal hepatocellular necrosis with associated increases in alt, ast, alkaline phosphatase and/or bilirubin.
fil-klieb, simeprevir kien assoċjat ma’ nekrosi epatoċellulari multifokali riversibbli b’żidiet assoċjati fl-alt, ast, alkaline phosphatase u/jew bilirubin.

progressive multifocal leukoencephalopathy (pml) has been reported under fingolimod treatment since marketing authorisation (see section 4.8).
kienet irrappurtata lewkoenċefaloptija multifokali progressiva (pml) waqt it-trattament b’fingolimod minn mindu nħarġet l-awtorizzazzjoni għat-tqegħid fis-suq (ara sezzjoni 4.8).

such infections include latent viral reactivation, such as hepatitis b or hepatitis c reactivation and infections caused by polyomaviruses (bk virus associated nephropathy, jc virus associated progressive multifocal leukoencephalopathy pml) .
infezzjonijiet bħal dawn jinkludu attivazzjoni mill-ġdid ta’ virusis mhux attivi, bħal attivazzjoni mill- ġdid tal-epatite b jew tal-epatite Ċ u infezzjonijiet ikkawżati minn poliomavirusis (nefropatija assoċjata mal-virus bk, lewkoenċefalopatija multifokali progressiva pml assoċjata mal-virus jc).

rare side effects that may occur in less than 1 in 1000 patients: • unusual infections (so-called “ opportunistic infections”) • progressive multifocal leukoencephalopathy (pml), a rare brain infection.
effetti sekondarji rari li jistgħu jseħħu f’ inqas minn 1 minn kull 1000 pazjent: • infezzjonijiet mhux tas- soltu (hekk magħrufa “ infezzjonijiet opportunistiċi ”) • lewkoenċefalopatija multifokali progressiva (pml), infezzjoni rari tal- moħħ.